{"id":"NCT00606229","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode","officialTitle":"A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2008-02-01","resultsPosted":"2014-03-13","lastUpdate":"2014-03-13"},"enrollment":41,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar I Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["OPC-14597"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"To assess the safety and efficacy of long-term administration of aripiprazole in combination with mood stabilizer (lithium or valproate) in an unblinded manner in patients with Bipolar I Disorder experiencing a manic or mixed episode","primaryOutcome":{"measure":"Young Mania Rating Scale (YMRS)","timeFrame":"Day 1 and Day 168 or time of discontinuation","effectByArm":[{"arm":"Aripiprazole","deltaMin":-18.8,"sd":9.86}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":11},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":41},"commonTop":["Akathisia","Somnolence","Nausea","Tremor","Blood Creatine Phosphokinase Increased"]}}